8 completed, 1 terminated. 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 8, Terminated 1 |
Follow Recurrent Uterine Sarcoma: new trials by email Literature Review of Recurrent Uterine Sarcoma trials Research Report on Recurrent Uterine Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus temsirolimus - Recurrent Uterine Sarcoma, Uterine Carcinosarcoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 8 | 2010-01-01 | 2016-11-09 |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery therapeutic angiotensin-(1-7), laboratory biomarker analysis - Bone Cancer, Chondrosarcoma | Phase 2 | Completed | Wake Forest University Health Sciences | 20 | 2009-10-01 | 2018-07-05 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma saracatinib - Adult Fibrosarcoma, Adult Leiomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2008-02-01 | 2018-06-29 |
| Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus sunitinib malate - Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 44 | 2006-10-01 | 2019-07-23 |
| Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma ziv-aflibercept - Fallopian Tube Cancer, Female Reproductive Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 63 | 2006-09-01 | 2015-12-07 |
| Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma sorafenib tosylate - Adult Angiosarcoma, Adult Epithelioid Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 147 | 2005-09-01 | 2014-05-23 |
| Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer sorafenib tosylate - Recurrent Uterine Sarcoma, Stage III Uterine Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 56 | 2005-02-01 | 2015-11-20 |
| Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer imatinib mesylate, laboratory biomarker analysis - Recurrent Uterine Sarcoma, Uterine Carcinosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 26 | 2004-01-01 | 2019-07-24 |
Sarcoma (3) · Carcinoma, Ovarian Epithelial (2) · Fallopian Tube Neoplasms (2) · Histiocytoma, Malignant Fibrous (2) · Leiomyosarcoma (2) · Bone Neoplasms (1) · Chondrosarcoma (1) · Dermatofibrosarcoma (1) · Endometrial Neoplasms (1) · Fibrosarcoma (1) · Hemangiosarcoma (1) · Liposarcoma (1) · Neurofibrosarcoma (1) · Osteosarcoma (1) · Rhabdomyosarcoma (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Neoplasms by Site (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Adnexal Diseases (2) · Carcinoma (2) · Endocrine Gland Neoplasms (2)
Sorafenib (2) · Imatinib Mesylate (1) · Radiosurgery (1) · Sirolimus (1) · Sunitinib (1) · aflibercept (1) · angiotensin I (1-7) (1) · saracatinib (1) · temsirolimus (1)
National Cancer Institute (NCI) (7) · Case Comprehensive Cancer Center (1) · Wake Forest University Health Sciences (1)
United States (9) · Canada (3)
Amit Oza (1) · Gini Fleming (1) · Margaret von Mehren (1) · Mark Einstein (1) · Martee Hensley (1) · Robert DeBernardo, MD (1) · Robert Maki (1) · Warner Huh (1) · William Petty (1)
N01CM62203 (3), N01CM62201 (2), U10CA027469 (2), N01CM00038 (1), N01CM62206 (1), N01CM62209 (1), P30CA008748 (1), P30CA013330 (1)